Medicine
Vancomycin 250 mg capsule
Vancomycin 250 mg capsule is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Vancomycin
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 50 capsules, 2 blister pack, 100 capsules and 16 more
- Manufacturers
- Avet PharmaceuticalsIndiaStrides PharmaIndiaAdvanced Rx of TennesseeANI PharmaceuticalsPAI PharmaBryant Ranch PrepackCameron Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07AA09 Vancomycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 October 2015
- Identifiers
- RxCUI 313570, 313571DailyMed set ID fac438bd-e08f-438d-ab64-426fc5c5450e, ae6efaaf-37eb-4510-ba71-5f3dc3abdbd3, 3707ad2e-5c82-4111-a370-e518e5e7e4c5 +5NDC 64380-730, 0121-1033, 62559-391 +5Application ANDA065490, ANDA065478, NDA050606 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 capsule in 1 bottle | 23155-859-25 | Avet PharmaceuticalsIndia | 25 June 2023 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 23155-859-78 | Avet PharmaceuticalsIndia | 25 June 2023 |
| 50 capsule in 1 bottle | 23155-968-25 | Avet PharmaceuticalsIndia | 10 August 2026 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 23155-968-78 | Avet PharmaceuticalsIndia | 10 August 2026 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 64380-730-02 | Strides PharmaIndia | 1 January 2026 |
| 50 capsule in 1 bottle | 64380-730-03 | Strides PharmaIndia | 1 January 2026 |
| 100 capsule in 1 bottle | 64380-730-04 | Strides PharmaIndia | 1 January 2026 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 62559-391-20 | ANI Pharmaceuticals | 26 October 2015 |
| 50 capsule in 1 bottle | 62559-391-50 | ANI Pharmaceuticals | 20 December 2016 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 42494-451-20 | Cameron Pharmaceuticals | 15 January 2024 |
| 2 blister pack in 1 carton / 10 capsule in 1 blister pack | 0121-1033-20 | PAI Pharma | 1 May 2026 |
| 50 capsule in 1 bottle | 0121-1033-50 | PAI Pharma | 1 May 2026 |
| 20 capsule in 1 bottle | 80425-0514-1 | Advanced Rx of Tennessee | 18 April 2025 |
| 30 capsule in 1 bottle | 80425-0514-2 | Advanced Rx of Tennessee | 18 April 2025 |
| 60 capsule in 1 bottle | 80425-0514-3 | Advanced Rx of Tennessee | 18 April 2025 |
| 90 capsule in 1 bottle | 80425-0514-4 | Advanced Rx of Tennessee | 18 April 2025 |
| 40 capsule in 1 bottle | 80425-0514-5 | Advanced Rx of Tennessee | 18 April 2025 |
| 50 capsule in 1 bottle | 80425-0514-6 | Advanced Rx of Tennessee | 18 April 2025 |
| 50 capsule in 1 bottle | 72162-2306-4 | Bryant Ranch Prepack | 13 May 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 April 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vancomycin 250 mg capsule.
Other strengths and forms of Vancomycin
Clinical summary
Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VancomycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- vancomycin hydrochloride prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Vancomycin 250 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.